Clinical research on COVID-19 found that levels of MPO were significantly upregulated in the serum of COVID-19 patients compared with healthy individuals, and serum MPO levels in the recovered population were reduced to levels comparable to those in healthy people [21]. The gene discussed is MPO; the disease is COVID-19.